Research study Program year 2025 Source: CMS Open Payments

A Phase 2B, Randomized, Double-Blind, Parallel Group, Placebo Controll

Research payments

$1,525,098

457 payments

Through program year 2025, $1,525,098 in research payments was reported against A Phase 2B, Randomized, Double-Blind, Parallel Group, Placebo Controll, across 457 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$591,629	222
2024	Research	$880,936	219
2023	Research	$52,533	16

Breakdown

Who paid Research payments · program years 2023–2025

GlaxoSmithKline, LLC. $1,525,098 457 payments

Who received the money Research payments · program years 2023–2025

Javara INC Organisation paid for research $257,929 75 payments
Elligo Health Research INC Organisation paid for research $147,974 26 payments
Northridge Clinical Trials Organisation paid for research $114,690 46 payments
Nuline Clinical Trial Center Organisation paid for research $112,940 36 payments
Icahn School Of Medicine At Mt Organisation paid for research $112,460 1 payment
Clinical Science Institute Organisation paid for research $101,864 15 payments
Sadick Research Group Organisation paid for research $88,735 17 payments
Cr Services Acquisition US LLC Dba Centricity Research Organisation paid for research $82,931 64 payments
First Oc Dermatology Research INC Organisation paid for research $63,784 18 payments
ICAHN School of Medicine at Mount Sinai Organisation paid for research $59,476 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.